Literature DB >> 30665560

Burden, access, and disparities in kidney disease.

Deidra C Crews1, Aminu K Bello2, Gamal Saadi3.   

Abstract

Entities:  

Keywords:  acute kidney injury; end stage renal disease; global health; health equity; social determinants of health

Year:  2019        PMID： 30665560     DOI： 10.1016/j.kint.2018.11.007

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  11 in total

Review 1.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

Review 2.  Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.

Authors:  John S Thurlow; Megha Joshi; Guofen Yan; Keith C Norris; Lawrence Y Agodoa; Christina M Yuan; Robert Nee
Journal:  Am J Nephrol       Date:  2021-03-22       Impact factor: 4.605

3.  The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.

Authors:  Thanutchaporn Kumrungsee; Taishi Kariya; Kotaro Hashimoto; Takayuki Koyano; Nao Yazawa; Takao Hashimoto; Yohei Sanada; Makoto Matsuyama; Yusuke Sotomaru; Hiroaki Sakurai; Fons A J van de Loo; Noriyuki Yanaka
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

4.  Rationale and Design for a Phase 1 Study of N-Acetylmannosamine for Primary Glomerular Diseases.

Authors:  Marjan Huizing; Tal Yardeni; Federico Fuentes; May C V Malicdan; Petcharat Leoyklang; Alexander Volkov; Benjamin Dekel; Emily Brede; Jodi Blake; Alva Powell; Harish Chatrathi; Yair Anikster; Nuria Carrillo; William A Gahl; Jeffrey B Kopp
Journal:  Kidney Int Rep       Date:  2019-06-25

5.  Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.

Authors:  Marcela Agudelo-Botero; María Cecilia González-Robledo; Hortensia Reyes-Morales; Liliana Giraldo-Rodríguez; Mario Rojas-Russell; Dolores Mino-León; Dayan Irene Ocampo-Morales; Rafael Valdez-Ortiz
Journal:  Int J Equity Health       Date:  2020-06-08

6.  Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017.

Authors:  Marcela Agudelo-Botero; Rafael Valdez-Ortiz; Liliana Giraldo-Rodríguez; María Cecilia González-Robledo; Dolores Mino-León; María Fernanda Rosales-Herrera; Lucero Cahuana-Hurtado; Mario Enrique Rojas-Russell; Claudio Alberto Dávila-Cervantes
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

7.  Serum Creatinine Electrochemical Biosensor on Printed Electrodes Using Monoenzymatic Pathway to 1-Methylhydantoin Detection.

Authors:  Pallavi Dasgupta; Vinay Kumar; Patnam R Krishnaswamy; Navakanta Bhat
Journal:  ACS Omega       Date:  2020-08-27

Review 8.  The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation.

Authors:  Sam Kant; Steven P Menez; Mohamed Hanouneh; Derek M Fine; Deidra C Crews; Daniel C Brennan; C John Sperati; Bernard G Jaar
Journal:  BMC Nephrol       Date:  2020-10-27       Impact factor: 2.388

9.  International collaborative efforts to establish kidney health surveillance systems.

Authors:  Barnaby D Hole; Katharine M Evans; Rhodri Pyart; M Razeen Davids; Carlota Gonzalez Bedat; Norio Hanafusa; David C H Harris; Kitty J Jager; Vivekanand Jha; Kirsten L Johansen; Stephen McDonald; Ikuto Masakane; Guillermo Rosa-Diez; Rajiv Saran; James B Wetmore; Fergus J Caskey
Journal:  Kidney Int       Date:  2020-10       Impact factor: 10.612

10.  Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.

Authors:  Huixian Li; Wanhong Lu; Ani Wang; Hongli Jiang; Jun Lyu
Journal:  J Diabetes Investig       Date:  2020-08-17       Impact factor: 4.232
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.